PATENT CLAIM ANALYSIS

Application Number: 16372958
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-07
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of conditions such as pain.

Claim (Index 1):
A method of treating pain comprising: orally administering a solid dosage form to a human being for at least six consecutive days, wherein the solid dosage form comprises: 1) a complex of meloxicam and a sulfobutyl ether \u03b2-cyclodextrin (SBE\u03b2CD), 2) a bicarbonate, and 3) esomeprazole, wherein orally administering the solid dosage form to the human being results in a T max  of meloxicam that is shorter than a T max  of a reference solid dosage form that: 1) contains the same amount of meloxicam, 2) does not contain an SBE\u03b2CD, and 3) does not contain a bicarbonate, and wherein the average gastric pH of the human being on the sixth consecutive day is at least 3.5.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 100.0
- Lexical Diversity: 1.35135
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15936176', '16372977', '16181086', '15989734', '16248449']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8074425634578292
- 35 USC 102 Novelty (BERT): 0.5608276705448927
- Combined Prediction Score: 0.7827810741665355
- Mean Citation Score: 410.306872
- Max Citation Score: 420.07852
- Similarity Product: 336.4345194843626

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test